Evidence map›Paper›PMID 41612516›Full record

ArticleImplementation science communications2026

Psychometric properties of the Clinical Sustainability Assessment Tool (CSAT) short form across three research centers evaluating effectiveness and implementation of a cancer symptom surveillance and management intervention.

James L Merle, Maja Kuharic, David Cella, Sandra A Mitchell, Jessica D Austin, Jennifer L Ridgeway, Michael J Hassett, Roshan Paudel, Ann Marie Flores, Lisa DiMartino and 4 more

Abstract read
In one paragraph

Article in Implementation science communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

James L MerleIntermountain Healthcare Department of Population Health Sciences, Spencer Fox Eccles School of Medicine at the University of Utah, 295 Chipeta Way, Salt Lake City, UT, 84108, USA. James.merle@utah.edu.ORCID http://orcid.org/0000-0001-9646-2733
Maja KuharicDepartment of Medical Social Sciences, Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
David CellaDepartment of Medical Social Sciences, Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
Sandra A MitchellDivision of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Jessica D AustinDivision of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ, USA.
Jennifer L RidgewayRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery and Division of Health Care Delivery Research, Mayo Clinic, Rochester, MN, USA.
Michael J HassettDepartments of Medical Oncology and Quality & Patient Safety, Dana-Farber Cancer Institute, Boston, MA, USA.
Roshan PaudelDana-Farber Cancer Institute, Boston, MA, USA.
Ann Marie FloresDepartment of Medical Social Sciences, Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
Lisa DiMartinoPeter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Wynne E NortonDivision of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Andrea L ChevilleDepartment of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, USA.
Justin D SmithIntermountain Healthcare Department of Population Health Sciences, Spencer Fox Eccles School of Medicine at the University of Utah, 295 Chipeta Way, Salt Lake City, UT, 84108, USA.ORCID http://orcid.org/0000-0003-3264-8082
IMPACT Consortium

Funding

The Harvard Clinical and Translational Science CenterUL1TR002541 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2018 to 2022
$93.0M
Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
UNIVERSITY OF UTAH MEDICAL INFORMATICS TRAININGT15LM007124 · NLM · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Karen Louise Eilbeck · 1997 to 2026
$22.0M
SIMPRO Research Center: Integration and Implementation of PROs for Symptom Management in Oncology PracticeUM1CA233080 · NCI · DANA-FARBER CANCER INST · PI HASSETT, MICHAEL JAMES, OSAROGIAGBON, RAYMOND U · 2018 to 2023
$9.1M
Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical TrialUM1CA233033 · NCI · MAYO CLINIC ROCHESTER · PI CHEVILLE, ANDREA LYNNE · 2018 to 2018
$8.7M
Implementation and Evaluation of an Expanded Bilingual Electronic Symptom Management Program across a Multi-site, Fully-integrated Comprehensive Cancer CenterUM1CA233035 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CELLA, DAVID · 2018 to 2021
$8.1M
Coordinating Center for Research Centers for Improving Management of Symptoms During and Following Cancer TreatmentU24CA232980 · NCI · RESEARCH TRIANGLE INSTITUTE · PI ARDINI, MARY-ANNE · 2018 to 2023
$3.4M
Clinical and Translational Science Awards UL1TR002377Clinical and Translational Sciences Awards UL1TR002541NCATS NIH HHS UL1 TR001422NCATS NIH HHS UL1 TR002377NCATS NIH HHS UL1 TR002541NCI NIH HHS U24 CA232980NCI NIH HHS U24CA232980NCI NIH HHS UM1 CA233033NCI NIH HHS UM1CA233033NCI NIH HHS UM1 CA233035NCI NIH HHS UM1CA233035NCI NIH HHS UM1 CA233080NCI NIH HHS UM1CA233080NLM NIH HHS T15 LM007124U.S. National Library of Medicine T15LM007124
6 · The paper itself

Abstract

objectiveThe Clinical Sustainability Assessment Tool (CSAT) is designed to capture determinants of sustainable clinical practices over time. Although the full 49-item CSAT instrument has demonstrated strong psychometric properties, the 21-item short form has had limited evaluation. This study aimed to assess the CSAT short form (CSAT Short) across different respondent characteristics and care delivery settings.

methodsWe evaluated the CSAT Short in a sample of healthcare personnel (N = 256 respondents) drawn from across three hybrid effectiveness-implementation studies in a research consortium, all of which tested routine symptom surveillance and integration of symptom management interventions in ambulatory oncology care settings in the US. Confirmatory factor analyses (CFA) and mIRT were conducted to assess the CSAT Short's fit to the hypothesized factor structure. Multiple-group CFA was used to test for measurement invariance across groups of respondents with different professional roles, years in current role, and different work settings.

resultsThe hypothesized seven factor structure of the CSAT Short exhibited good fit to the data and strong internal consistency in our sample of healthcare personnel drawn from across three large pragmatic trials (CFI = .99,TLI = .98,X

conclusionsThe CSAT Short is recommended to assess sustainability in oncology settings, though users should be cautious when comparing scores across different healthcare systems. Tests of invariance were nonsignificant except for variance by Research Center. Despite some items exhibiting suboptimal fit in mIRT, the overall model fit and reliability were strong. This study advances our understanding of sustainability measurement and the applicability of the CSAT Short across implementation settings and respondents.

Indexed as

CancerClinical Sustainability Assessment ToolConfirmatory Factor AnalysisFactor AnalysisImplementation ScienceItem Response Theory

Identifiers

PMID41612516
PMCPMC12934111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.